Completed NA INTERVENTIONAL 3-arm NCT06195137

Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)

Efficacy of Caffeine vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment

Sponsor: Lu Jiang

Conditions Burning Mouth Syndrome Caffeine

Interventions Alpha Lipoic Acid Caffeine

Updated 3 times since 2024 Last updated: Jan 5, 2024 Started: Dec 13, 2021 Primary completion: Jun 15, 2023 Completion: Jun 23, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06195137, this NA trial focuses on Burning Mouth Syndrome and Caffeine and remains completed. Sponsored by Lu Jiang, it has been updated 3 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2024 — Jul 2024 [monthly]

Completed NA

First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lu Jiang

Data source: Sichuan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chengdu, China